Watanabe J - Search Results

1

Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.

Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S, Shinohara N, Sazawa A, Fukushima S, Naito S. Tatsugami K, et al. Among authors: watanabe j. J Endourol. 2010 Nov;24(11):1807-11. doi: 10.1089/end.2010.0055. Epub 2010 Aug 14. J Endourol. 2010. PMID: 20707727 Free article. Clinical Trial.

2

Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan.

Nishiyama H, Habuchi T, Watanabe J, Teramukai S, Tada H, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. Nishiyama H, et al. Among authors: watanabe j. Eur Urol. 2004 Feb;45(2):176-81. doi: 10.1016/j.eururo.2003.09.011. Eur Urol. 2004. PMID: 14734003

3

Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.

Watanabe J, Nishiyama H, Okubo K, Takahashi T, Toda Y, Habuchi T, Kakehi Y, Tada M, Ogawa O. Watanabe J, et al. Urology. 2004 May;63(5):989-93. doi: 10.1016/j.urology.2003.11.031. Urology. 2004. PMID: 15135005

4

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.

Ito M, Habuchi T, Watanabe J, Higashi S, Nishiyama H, Wang L, Tsuchiya N, Kamoto T, Ogawa O. Ito M, et al. Among authors: watanabe j. Urology. 2004 Jul;64(1):74-8. doi: 10.1016/j.urology.2004.03.001. Urology. 2004. PMID: 15245939

5

Over expression of thioredoxin-1 in transgenic mice attenuates germ cell apoptosis induced by experimental cryptorchidism.

Okubo K, Nakamura H, Watanabe J, Kamoto T, Yodoi J, Ogawa O, Nishiyama H. Okubo K, et al. Among authors: watanabe j. J Urol. 2004 Dec;172(6 Pt 1):2479-82. doi: 10.1097/01.ju.0000138474.13112.67. J Urol. 2004. PMID: 15538295

6

The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.

Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. Matsui Y, et al. Among authors: watanabe j. Int J Clin Oncol. 2005 Apr;10(2):133-8. doi: 10.1007/s10147-004-0474-5. Int J Clin Oncol. 2005. PMID: 15864700

7

Clinical evaluation of serum p53 antibodies in patients with upper urinary tract tumors.

Watanabe J, Nishiyama H, Kawanishi H, Ito M, Kamoto T, Ogawa O. Watanabe J, et al. J Urol. 2005 Jul;174(1):73-5. doi: 10.1097/01.ju.0000162053.44205.6e. J Urol. 2005. PMID: 15947581

8

Micropapillary bladder cancer.

Nishizawa K, Kobayashi T, Mitsumori K, Ide Y, Watanabe J, Ogura K. Nishizawa K, et al. Among authors: watanabe j. Int J Urol. 2005 May;12(5):506-8. doi: 10.1111/j.1442-2042.2005.01075.x. Int J Urol. 2005. PMID: 15948755

9

Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population.

Ito M, Nishiyama H, Watanabe J, Kawanishi H, Takahashi T, Kamoto T, Habuchi T, Ogawa O. Ito M, et al. Among authors: watanabe j. Jpn J Clin Oncol. 2006 Feb;36(2):116-20. doi: 10.1093/jjco/hyi225. Epub 2006 Jan 17. Jpn J Clin Oncol. 2006. PMID: 16418181

10

Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.

Watanabe J, Nishiyama H, Matsui Y, Ito M, Kawanishi H, Kamoto T, Ogawa O. Watanabe J, et al. Oncogene. 2006 Apr 20;25(17):2500-8. doi: 10.1038/sj.onc.1209162. Oncogene. 2006. PMID: 16518417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,105 results

Search Page

Filters